Successful treatment of ulcerated hemangiomas with a dual-wavelength 595- and 1064-nm laser system

Abstract

Background: Pulsed dye laser (PDL) treatment has been shown to be effective for the management of ulcerated areas of hemangiomas. However, targeting deeper dermal lesions requires a laser system that penetrates more deeply than a PDL. Thus, we applied a dual-wavelength 595- and 1064-nm laser system to the treatment of ulcerated hemangiomas. Materials and methods: Twenty-two infants with ulcerated hemangiomas (mean are, 3.8 cm²) were reviewed. Ulcers were treated by debridement and the surface received 595-nm PDL treatment at 4–5 J/cm² with a pulse width of 0.5 ms. Then, the remaining hemangioma excluding the ulcerated portion was treated with dual-wavelength laser. Laser treatment was repeated at two-week intervals until cutaneous healing was observed. Results: Ulcerative lesions in 20 of the 22 patients (90.9%) healed entirely within 2 weeks following the first laser treatment. Two patients also required oral steroids, and one patient underwent two laser treatments. The follow-up period ranged from 6 to 24 months, and no evidence of recurrent ulceration or hemangioma regrowth was observed. Conclusions: Our findings confirm that PDL treatment leads to a rapid decrease in pain and initiation of the healing process and indicate that dual-wavelength laser treatment offers rapid healing with few adverse effects.

Keywords:

• Dual-wavelength laser system
• ulcerated hemangioma
• infant

View correction statement:

Correction to: Successful treatment of ulcerated hemangiomas with a dual-wavelength 595- and 1064-nm laser system

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.